Imagine a future where chemists could restructure the morphine molecule to have the opiate pain management value but not the addictive side effect. That is one possible outcome of an exciting new process being reported in Science magazine from the chemistry lab of Richmond Sarpong at UC Berkeley.
Imagine a future where chemists could restructure the morphine molecule to have the opiate pain management value but not the addictive side effect. That is one possible outcome of an exciting new process being reported in Science magazine from the chemistry lab of Richmond Sarpong at UC Berkeley.